Namrata Bhutani et al. 2024. Targeted Therapy for CML Patients on Imatinib: Role of Novel Variants of Human Organic Cationic Transporter 1 (hOCT1). Disease and Health Research: New Insights Vol. 3. (Aug. 2024), 81–87. DOI:https://doi.org/10.9734/bpi/dhrni/v3/1656.